Nikon launches spectral imaging products for drug R&D
Nikon Instruments have launched a series of software and application enhancements for spectral imaging applications, which are used extensively in drug discovery and cell biology.
Archives for November 10, 2005
Roche to meet flu vaccine demands
With the aim of meeting government's needs for pandemic planning, Roche has announced it is on track to produce 300 million Tamiflu treatments annually from 2007, after stepping up its production capacity.
Cyclacel applies for Aurora Kinase inhibitor IND
A small molecule drug, which has been developed to treat solid tumour and haematological cancer, has entered an Investigational New Drug (IND) application that represents the emergence of aurora kinase inhibitors as a viable cancer treatment.
DSM continue to expand in emerging economies
DSM is expanding its anti-infectives production facilities in India, as part of a global restructuring program to improve profitability and retain DSM's position in the penicillin market.
Foss launches new MultiVial Analyser
Foss has introduced the latest in its NIRSystems analyser range, featuring the company's XDS near-infrared (NIR) technology, for improved analytical performance in harsh industrial manufacturing environments.
Varian acquires UK's Polymer Labs
Varian has announced it is to acquire Polymer Laboratories for $42 million (€35.7 million)in a transaction that adds consumables and instrumentation for Gel Permeation Chromatography (GPC) analysis to its product portfolio.
Sanofi Pasteur to license novel vaccine adjuvant
Sanofi Pasteur has entered into a license and supply agreement with Eisai for the use of their novel adjuvant designed to boost the immune response to a broad range of vaccines.
Sophion deal aims to expand into Japanese market
Sophion Bioscience and Physio-Tech have signed an agreement in which Physio-Tech will become the exclusive distributor of Qpatch 16 systems in Japan, signifying its introduction into the Asian market.
Evotec 3Q continues to show improvement
German biotech company Evotec OAI boosted its third quarter revenues by 18 per cent to €19 million, despite the difficult operating environment for companies supplying drug discovery technologies, continuing its recovery from a weak start to the year.
Ferro develops high-purity parenteral sugars
Ferro introduced its new high-purity, low-endotoxin sucrose, maltose and trehalose sugars at the recent CPhI in Madrid, designed to improve product quality and broaden the market for injectable protein-based APIs.